Better Targeting, Delivery of RNAi Therapies
Forgoing the Comforts of Small Molecules and Antibodies, Some Drug Developers Are Setting Their Sights on RNAi-Based Therapeutics
Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Doron Lancet works in the Department of Molecular Genetics at the Weizmann Institute of Science.
More GEN Content From This Contributor
- Columns: Gene Trends: Which Ones Should You Be Studying Now?
- Columns: Gene Trends: Eye-Openers for Unusual Gene Variations
- GEN Exclusives: Gene Trends: On Muscle, Fat, and Brain